Evidence map›Paper›PMID 26711789›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck.

Hongliang Liu, Fengqin Gao, Kristina R Dahlstrom, Guojun Li, Erich M Sturgis, Jose P Zevallos, Qingyi Wei, Zhensheng Liu

Abstract read
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Levels of MicroRNA Heterogeneity in Cancer Biology.Molecular diagnosis & therapy · 2017
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Hongliang LiuDuke Cancer Institute, Duke University Medical Center, 905 South Lasalle Street, Durham, NC, 27710, USA.
Fengqin GaoDuke Cancer Institute, Duke University Medical Center, 905 South Lasalle Street, Durham, NC, 27710, USA.
Kristina R DahlstromDepartments of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.
Guojun LiDepartments of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.
Erich M SturgisDepartments of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA.
Jose P ZevallosDepartment of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Qingyi WeiDuke Cancer Institute, Duke University Medical Center, 905 South Lasalle Street, Durham, NC, 27710, USA. qingyi.wei@duke.edu.
Zhensheng LiuDuke Cancer Institute, Duke University Medical Center, 905 South Lasalle Street, Durham, NC, 27710, USA. zhensheng.liu@duke.edu.
The University of Texas MD Anderson Cancer Center · USDuke Medical Center · USDuke University · USUniversity of North Carolina at Chapel Hill · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
Molecular Epidemiology of Head and Neck CancerR01ES011740 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2001 to 2012
$6.3M
Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck CancerR01CA131274 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2009 to 2013
$3.0M
NCI NIH HHS P30 CA014236NCI NIH HHS R01 CA131274NIEHS NIH HHS R01 ES011740
6 · The paper itself

Abstract

DNA double-strand breaks (DSBs) are one of the most serious forms of DNA damage to the cell, causing genomic instability and ultimately carcinogenesis. In this study, we hypothesized that single nucleotide polymorphisms (SNPs) at the micro RNA (miRNA)-binding sites of DSB repair genes may influence cancer risk by dysregulating target gene expression. To test our hypothesis, we firstly performed functional prediction for common SNPs in DSB genes and found 12 potentially functional SNPs located at the miRNA-binding sites. We then investigated their associations with risk of squamous cell carcinoma of the head and neck (SCCHN) in 1087 patients and 1090 cancer-free controls in a non-Hispanic white population. As a result, SNP rs7213430 in BRIP1 was found to be significantly associated with cancer risk (P trend = 0.021). Compared with the AA homozygotes, the G allele carriers had an increased risk of SCCHN (adjusted OR 1.16, 95 % CI 1.02-1.31). Marginal significance was found for another SNP rs15869 in BRCA2 (P = 0.053). Further, functional analyses showed that SNP rs7213430 is within the miR-101 seed-binding region, and the variant G allele could lead to significantly lower luciferase activity and BRIP1 mRNA expression, compared to the A allele with the presence of miR-101. Our results suggested that SNP rs7213430 in the 3'-UTR of BRIP1 might contribute to SCCHN susceptibility by affecting the binding activity of miR-101 and resulting in a decreased BRIP1 expression. Additional larger population and functional studies are warranted to confirm our findings.

Indexed as

3' Untranslated RegionsBinding SitesBiomarkers, TumorCarcinoma, Squamous CellCase-Control StudiesDNA-Binding ProteinsFanconi Anemia Complementation Group ProteinsFemaleFollow-Up StudiesGenetic Predisposition to DiseaseGenotypeHead and Neck NeoplasmsHumansMicroRNAsMiddle AgedNeoplasm Staging3' Untranslated RegionsBiomarkers, TumorBRIP1 protein, humanDNA-Binding ProteinsFanconi Anemia Complementation Group ProteinsMicroRNAsRNA HelicasesRNA, MessengerDNA double strands breakGenetic susceptibilityHead and neck cancerMicroRNAPolymorphism

Identifiers

PMID26711789
PMCPMC4958391
OpenAlexW2282613530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.